Cita APA (7a ed.)

T, K., K, O., Y, M., I, N., K, S., M, O., . . . N, I. (2018). Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: A meta-analysis of double-blind, randomized placebo-controlled trials. Dove Medical Press.

Cita Chicago Style (17a ed.)

T, Kishi, et al. Comparison of the Efficacy and Safety of 4 and 2 Mg/day Brexpiprazole for Acute Schizophrenia: A Meta-analysis of Double-blind, Randomized Placebo-controlled Trials. Dove Medical Press, 2018.

Cita MLA (8a ed.)

T, Kishi, et al. Comparison of the Efficacy and Safety of 4 and 2 Mg/day Brexpiprazole for Acute Schizophrenia: A Meta-analysis of Double-blind, Randomized Placebo-controlled Trials. Dove Medical Press, 2018.